Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)
China flag China · Delayed Price · Currency is CNY
4.130
-0.040 (-0.96%)
Oct 28, 2026, 11:29 AM CST

SHA:600572 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
832.421,6741,3222,5702,4682,573
Trading Asset Securities
50-----
Cash & Short-Term Investments
882.421,6741,3222,5702,4682,573
Cash Growth
5.58%26.60%-48.56%4.13%-4.09%63.19%
Accounts Receivable
2,0571,5201,6651,7561,6381,671
Other Receivables
76.9662.4787.7438.2259.4184.42
Receivables
2,1341,5821,7531,7941,6971,755
Inventory
1,0851,2301,2661,3331,1281,044
Prepaid Expenses
-0.030.260.610.891.02
Other Current Assets
990.1671.9578.1877.26101.7492.17
Total Current Assets
5,0914,5584,4195,7755,3955,466
Property, Plant & Equipment
2,6682,8723,0473,0483,2203,251
Long-Term Investments
1,9491,8971,7741,7231,6291,881
Goodwill
184.72184.72184.72184.72184.72184.72
Other Intangible Assets
349.15371.95349.19355.45390.79362.43
Long-Term Deferred Tax Assets
57.6538.8341.1678.9455.4627.5
Long-Term Deferred Charges
15.5322.5967.4646.3540.6666.81
Other Long-Term Assets
152.439.3719.3125.8614.8234.78
Total Assets
10,4689,9849,90211,23810,93111,274

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
926.84848.28868.76819.53629.13540.19
Accrued Expenses
251.42970.32963.411,2051,005873.5
Short-Term Debt
115.02157.42210.56849.71717.731,344
Current Portion of Long-Term Debt
54.05100.0391.0777.79138.63129.65
Current Portion of Leases
-5.272.234.46.154.63
Current Income Taxes Payable
134.948.5944.8456.4551.3828.5
Current Unearned Revenue
42.6737.237.6843.65113.336.68
Other Current Liabilities
1,200271.29297.88115.87128.07210.8
Total Current Liabilities
2,7252,4382,5163,1732,7893,168
Long-Term Debt
20.0140117.87305.03330.39.5
Long-Term Leases
0.50.992.050.723.974
Long-Term Unearned Revenue
103.63109.88116.21141.11154.22146.83
Long-Term Deferred Tax Liabilities
238.93241.95235.6268.27328.79310.3
Other Long-Term Liabilities
4.060.960.940.930.920.92
Total Liabilities
3,0922,8322,9893,8893,6073,639

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
2,5402,5352,5832,5702,5702,570
Additional Paid-In Capital
305.37284.02285.66210.32149.54359.76
Retained Earnings
4,3544,1684,2514,2614,1944,271
Treasury Stock
---299.99---
Comprehensive Income & Other
62.4360.15-0.11-0.010.10.27
Total Common Equity
7,2627,0476,8207,0416,9147,201
Minority Interest
114.12105.1192.97308.58410.18434.01
Shareholders' Equity
7,3767,1526,9137,3507,3247,635
Total Liabilities & Equity
10,4689,9849,90211,23810,93111,274

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
189.57303.7423.771,2381,1971,492
Net Cash (Debt)
692.851,370898.341,3321,2711,082
Net Cash Growth
59.61%52.51%-32.57%4.81%17.53%-
Net Cash Per Share
0.280.550.360.520.500.42
Filing Date Shares Outstanding
2,5492,5352,5192,5702,5702,570
Total Common Shares Outstanding
2,5492,5352,5192,5702,5702,570
Working Capital
2,3672,1201,9022,6032,6062,298
Book Value Per Share
2.852.782.712.742.692.80
Tangible Book Value
6,7286,4906,2866,5016,3386,654
Tangible Book Value Per Share
2.642.562.492.532.472.59
Buildings
-2,4032,4272,2502,1382,055
Machinery
-2,9242,7652,6552,2791,888
Construction In Progress
-72.77139.45238.37661.931,068